Knowledge Center
Patent / Jan 01, 1971
Mineral hydroxy acid esters of 9.alpha.-fluoro-16-methylprednisolone
Source:
US 3564028
Prepn. of the title compds., useful for the remission of pain, bleeding tendency, and fever, is described. Orthophosphoric acid (85%) is dehydrated; MeCN and Et3N added and the mixt. cooled to -20.degree. and ClCO2Et in MeCN added. The mixt. is stirred 0.5 hr followed by the addn. of prednisolone in MeCN and Et3N. The mixt. is refluxed 1 hr, and 2N NaOMe in MeOH added to yield Na salt of prednisolone 21-phosphate, m. 200.degree.. Similarly are prepd. 6 addnl. analogs.
Also in the Knowledge Center
/ Dec 01, 2015
The importance of human factors in inhaler development: The making of PowdAir®
Read more
Scientific Article
/ Nov 26, 2015
FDA Draft Guidance for Industry: Request for Quality Metrics – FDA-2015-D-2537
Read more
Scientific Article
Scientific Article